Share This

Public company info - Sinopharm Group Co. Ltd. - H Shares , 01099.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Sinopharm Group Co. Ltd. - H Shares, 01099.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12 2007-12 2006-12
Net Cash Flow from Operating Activities 25,362,875 13,382,206 14,810,087 22,218,369 6,421,228 5,940,580 11,303,860 15,331,231 6,953,987 6,022,937 4,822,557 1,847,146 1,709,331 1,549,465 955,240 671,829 787,527
Net Cash Flow from Return on Investments & Servicing of Finance -8,146,543 -7,910,635 -7,787,672 -8,279,867 -6,180,651 -4,778,112 -3,418,749 -3,175,860 -3,143,658 -2,637,419 -1,903,509 -1,231,780 -364,271 -1,366,006 -353,316 -133,805 -196,602
　Interest Received 74,558 84,712 91,526 89,229 94,684 62,367 66,829 71,318 39,114 42,530 0 0 65,789 25,889 23,828 13,191 11,159
　Interest Paid -4,777,933 -4,575,123 -4,643,625 -5,180,182 -4,052,378 -2,433,301 -1,994,076 -1,959,318 -2,201,302 -1,595,532 -1,297,821 -749,961 -314,349 -228,331 -244,171 -139,023 -95,755
　Dividend Received 565,093 435,977 419,300 360,007 396,692 229,894 121,633 104,937 97,243 86,966 116,372 88,081 49,238 43,855 25,293 29,670 15,411
　Dividend Paid -4,008,261 -3,856,201 -3,654,873 -3,548,921 -2,619,649 -2,637,072 -1,613,135 -1,392,797 -1,078,713 -1,171,383 -722,060 -569,900 -164,949 -1,207,419 -158,266 -37,643 -127,417
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -4,399,088 -4,074,121 -3,655,478 -3,441,273 -2,767,489 -2,731,912 -2,045,896 -1,770,785 -1,393,152 -1,081,643 -966,713 -827,877 -506,794 -431,706 -301,391 -230,649 -149,088
Net Cash Flow from Investing Activities -4,229,273 -1,787,651 -2,713,584 -7,245,203 -6,399,000 -3,451,914 -1,794,916 -1,772,723 -4,493,923 -4,195,871 -2,585,557 -2,918,910 -1,946,506 -3,381,990 -197,074 -57,258 -297,469
　Additions to Fixed Assets -2,224,454 -2,096,751 -1,921,759 -2,223,979 -3,239,894 -2,121,164 -1,212,093 -1,079,520 -1,643,407 -1,223,795 -1,422,290 -1,101,201 -1,515,847 -588,860 -298,603 -260,125 -260,028
　Disposal of Fixed Assets 173,219 167,149 230,792 173,101 171,572 127,566 327,373 72,046 20,719 76,130 426,898 160,189 66,849 49,697 43,201 103,970 46,748
　Increase in Investments -553,967 -581,858 -2,674,710 -1,402,167 -832,501 -1,365,632 -518,189 -319,849 -347,072 -350,793 -767,637 -1,616,206 -2,753,773 -3,030,116 -50,358 39,405 -90,217
　Decrease in Investments 134,821 82,610 303,942 107,858 60,454 3,518 166,615 115,399 -46,572 -151,031 8,846 4,198 2,887,352 197,785 116,017 59,492 6,028
　Net Cash Flow with Related Parties -4,251,802 4,626,687 273,098 1,047,556 2,709,412 1,509,690 581,019 0 94,701 209,471 133,486 435,468 143,070 637,971 -630,295 646,507 -24,856
　Others 2,492,910 -3,985,488 1,075,053 -4,947,572 -5,268,043 -1,605,892 -1,139,641 -560,799 -2,572,292 -2,755,853 -964,860 -801,358 -774,157 -648,467 622,964 -646,507 24,856
Net Cash Flow before Financing Activities 8,587,971 -390,201 653,353 3,252,026 -8,925,912 -5,021,358 4,044,299 8,611,863 -2,076,746 -1,891,996 -633,222 -3,131,421 -1,108,240 -3,630,237 103,459 250,117 144,368
Net Cash Flow from Financing Activities 3,092,713 -6,261,683 10,324,352 -4,355,462 16,990,546 9,049,258 1,580,247 -3,975,971 3,302,041 6,175,644 -2,707,993 8,747,735 1,015,099 9,134,348 -346,936 -133,318 343,006
　New Loans 89,086,340 74,557,348 78,158,753 51,537,255 51,725,497 48,114,187 27,583,853 34,100,446 31,858,148 30,222,658 21,932,118 14,352,764 4,819,503 5,737,521 1,416,467 1,435,823 1,774,229
　Loans Repayment -82,028,374 -82,605,708 -67,373,617 -54,323,484 -47,743,724 -38,466,987 -26,200,343 -40,963,884 -34,034,663 -31,436,597 -24,970,408 -13,166,504 -3,657,563 -6,021,178 -1,496,596 -1,690,990 -1,382,845
　Fixed Income/Debt Instruments 17,289,549 21,000,000 26,675,716 35,462,623 29,296,528 3,992,345 14,973,982 8,989,375 5,993,140 3,958,828 398,400 4,953,770 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments -17,003,000 -23,840,010 -31,010,000 -36,959,990 -19,000,000 -6,000,000 -14,000,000 -6,000,000 -5,000,000 0 0 0 0 0 0 0 0
　Equity Financing 0 0 3,567,383 0 0 0 0 0 4,390,715 3,224,560 0 2,834,740 0 8,528,205 0 0 0
　Net Cash Flow with Related Parties -4,251,802 4,626,687 273,098 1,047,556 2,709,412 1,509,690 581,019 0 94,701 209,471 133,486 435,468 143,070 637,971 -630,295 646,507 -24,856
　Others 0 0 33,019 -1,119,422 2,833 -99,977 -1,358,264 -101,908 0 -3,276 -201,589 -662,503 -289,911 251,829 363,488 -524,658 -23,522
Increase(Decrease) in Cash & Cash Equivalents 11,680,684 -6,651,884 10,977,705 -1,103,436 8,064,634 4,027,900 5,624,546 4,635,892 1,225,295 4,283,648 -3,341,215 5,616,314 -93,141 5,504,111 -243,477 116,799 487,374
Cash & Cash Equivalents at Beginning of Year 43,529,428 50,178,265 39,191,967 40,298,985 32,240,796 28,205,005 19,966,052 15,232,356 14,001,962 9,801,502 13,140,820 7,474,698 7,567,839 2,063,728 1,955,596 1,838,797 1,351,423
Net Cash Flow due to Change in Exchange Rate/Others 11,512 3,047 8,593 -3,582 -6,445 7,891 -17,839 50,906 5,099 -83,188 1,897 0 0 0 0 0 0
Cash & Cash Equivalents at End of Year 55,221,624 43,529,428 50,178,265 39,191,967 40,298,985 32,240,796 25,572,759 19,919,154 15,232,356 14,001,962 9,801,502 13,091,012 7,474,698 7,567,839 1,712,119 1,955,596 1,838,797
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand Thousand Thousand Thousand
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.